Demonstration of the Episwitch™ platform - DLBCL subtyping

This proof-of-concept study for identifying DLBCL subtypes using chromatin conformation signatures underlines some of the attractive features of EpiSwitch™ as a simple, accurate and cost-effective blood-based diagnostic platform.

Hunter, E., McCord, R., Ramadass, A.S. et al. Comparative molecular cell-of-origin classification of diffuse large B-cell lymphoma based on liquid and tissue biopsies. transl med commun 5, 5 (2020). https://doi.org/10.1186/s41231-020-00054-1